Abstract |
A 50-year-old woman was admitted because of high fever and fatigue. Proteinuria, hematuria, and elevated BUN (47.8 mg/dl) and creatinine (3.4 mg/dl) suggested rapidly progressive glomerulonephritis. The serological study revealed all negative results for rheumatoid factor, antinuclear antibody, serum cryoglobulins, MPO- ANCA, PR3-ANCA, and anti- streptolysin O. Antiglomerular basement membrane (GBM) antibody, as assessed by ELISA, was 11 EU (normal, <10). Kidney biopsy on the eighth hospital day demonstrated pauci-immune-type crescentic glomerulonephritis without ANCA. Methylprednisolone pulse therapy (500 mg/day, 3 days) and 45 mg/day prednisolone orally were started. At 3 weeks after kidney biopsy, the anti-GBM antibody value increased from 11 EU/ml to 116 EU/ml, and MPO and PR3-ANCA were still negative. HLA type was DR8 and DR 15(2), with a genotype of HLA-DRB1*08021 and HLA-DRB1*15011. The present case suggests that HLA-DR15 plays an important role on antibody production against alpha 3(IV) NC1 autoantigen after severe nephritis or tissue damage.
|
Authors | Wataru Kitagawa, Naoto Miura, Harutaka Yamada, Kazuhiro Nishikawa, Arao Futenma, Hirokazu Imai |
Journal | Clinical and experimental nephrology
(Clin Exp Nephrol)
Vol. 9
Issue 1
Pg. 69-73
(Mar 2005)
ISSN: 1342-1751 [Print] Japan |
PMID | 15830277
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Antibodies
- Autoantibodies
- Glucocorticoids
- HLA-DR Antigens
- HLA-DR Serological Subtypes
- HLA-DR15 antigen
- antiglomerular basement membrane antibody
- Prednisolone
- Methylprednisolone
|
Topics |
- Anti-Inflammatory Agents
(adverse effects, therapeutic use)
- Antibodies
(blood)
- Autoantibodies
- Drug Therapy, Combination
- Female
- Glomerulonephritis
(diagnostic imaging, drug therapy, immunology, pathology)
- Glucocorticoids
(adverse effects, therapeutic use)
- HLA-DR Antigens
(blood)
- HLA-DR Serological Subtypes
- Humans
- Methylprednisolone
(therapeutic use)
- Middle Aged
- Prednisolone
(adverse effects, therapeutic use)
- Radionuclide Imaging
|